NetworkNewsBreaks – Brain Scientific Inc. (BRSF)
Post# of 129
(Total Views: 138)
Posted On: 09/13/2021 3:46:19 PM
NetworkNewsBreaks – Brain Scientific Inc. (BRSF) Poised to Offer Solution to Rising Challenge Facing Global Health Systems
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more data. Research has demonstrated that COVID patients suffer from neurological symptoms. “However, the new comprehensive cross-country study recently published in the Journal of Neurology, Neurosurgery and Psychiatry reveals that neurological symptoms may actually be the norm rather than an exception.” As a result, Brain Scientific “could be the one offering a solution to the rising challenge global health systems face in the post-COVID world.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, offers next-generation technological solutions for the neurology market. The company’s two FDA-cleared devices, NeuroCap(TM) and NeuroEEG(TM), allow quick and reliable EEG testing in minutes and by any health care worker, not only specialized neurological technicians, bringing brain diagnostics to settings in which neurological testing was previously impossible or difficult. “As we learn more about COVID-19, it is becoming increasingly clear that neurological care in the post-COVID world will be crucial,” reads a recent article. This revelation comes amid findings by scientists who are starting to collect more and more data. Research has demonstrated that COVID patients suffer from neurological symptoms. “However, the new comprehensive cross-country study recently published in the Journal of Neurology, Neurosurgery and Psychiatry reveals that neurological symptoms may actually be the norm rather than an exception.” As a result, Brain Scientific “could be the one offering a solution to the rising challenge global health systems face in the post-COVID world.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Brain Scientific, Inc. (BRSF) Stock Research Links
Scroll down for more posts ▼